Related Experiment Video
Updated: Apr 1, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Priapism in Homozygous Sickle Cell Disease: A 40-year Study of the Natural History
1Sickle Cell Trust, 14 Milverton Crescent, Kingston 6, Jamaica. grserjeant@cwjamaica.com.
Insights
Priapism is common in sickle cell disease (SS disease), with incidence increasing in adolescence. While most cases resolve, severe priapism can lead to temporary impotence, advising caution with penile prostheses.
Area of Science:
- Hematology
- Urology
- Reproductive Medicine
Background:
- Sickle cell disease (SS disease) is a genetic blood disorder.
- Priapism, a prolonged erection, is a known complication of SS disease.
- Understanding its incidence and outcomes is crucial for patient management.
Purpose of the Study:
- To determine the incidence, pattern, and long-term outcomes of priapism in males with SS disease.
- To evaluate the impact of priapism on erectile function.
Main Methods:
- A retrospective review of 162 males with SS disease was conducted.
- Data were collected over periods up to 40 years from a screening of 100,000 deliveries in Jamaica.
- Priapism events and erectile function were assessed through direct questioning and medical records.
Main Results:
- Priapism occurred in 32.7% of patients, with incidence rising sharply in late adolescence.
- Cumulative incidence reached nearly 60% by age 40.
- Major priapism attacks (>6 hours) occurred in 17 patients, leading to temporary impotence in some, but with potential for recovery.
Conclusions:
- Stuttering priapism is common and should be routinely inquired about in SS disease patients.
- Prophylactic measures are recommended for frequent priapism episodes.
- Late recovery of erectile function suggests caution against early penile prosthesis insertion after major priapism events.
Objectives:
To describe the incidence, pattern, and outcome of priapism in homozygous sickle cell (SS) disease.
Methods:
Regular review, for periods up to 40 years, was done of all 162 males with SS disease detected during the screening of 100 000 consecutive non-operative deliveries at the main government maternity hospital in Kingston, Jamaica, between June 1973 and December 1981.
Results:
Priapism occurred in 52 (32.7%) patients overall, the incidence rising steeply in late adolescence to 32% by age 20 years and a cumulative incidence of nearly 60% of patients by age 40 years. Many cases were elicited only on direct questioning because of embarrassment and the lack of realization that priapism complicates SS disease. Initial events were recurrent stuttering episodes in 39 patients, a single short-term event in six patients and a major attack (more than six hours) in seven patients. Erectile function was preserved in almost all patients with simple stuttering or single events. Major attacks (> 6 hours) occurred in 17 patients, preceded by stuttering episodes in nine, by a single event in one, and occurring de novo in seven. In these, erectile function was unknown in five, deemed satisfactory in five (sometimes improving over three years), weak in three and impotence persisted in four (two with major attacks three and six months previously).
Conclusion:
A history of stuttering priapism should be routinely enquired and prophylactic measures used if attacks exceed once weekly. Major events generally result in short-term impotence, but the late recovery of erectile function cautions against the early insertion of penile prostheses.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Multiple Allele Traits
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...